Loading...
XNAS
XFOR
Market cap14mUSD
Jun 23, Last price  
2.42USD
1D
-9.36%
1Q
832.92%
IPO
-84.07%
Name

X4 Pharmaceuticals Inc

Chart & Performance

D1W1MN
P/E
—
P/S
5.48
EPS
—
Div Yield, %
—
Shrs. gr., 5y
77.13%
Rev. gr., 5y
%
Revenues
3m
0003,500,00003,000,0000002,557,000
Net income
-37m
L-62.98%
-13,218,000-22,975,000-33,877,000-43,021,000-56,604,000-62,131,000-88,696,000-93,867,000-101,167,000-37,450,000
CFO
-131m
L+35.63%
-10,816,000-21,639,000-27,871,000-40,903,000-48,055,000-58,818,000-70,905,000-77,102,000-96,512,000-130,901,000
Earnings
Aug 06, 2025

Profile

Actelis Networks, Inc., a networking solutions company, designs, develops, manufactures, and markets networking solutions for Internet of Things and telecommunication companies in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. It offers ethernet access devices, aggregation switches, broadband amplifiers, and repeaters, as well as element management systems software. The company also provides consulting, troubleshooting, remote support, training, product repairing, and software update services. It serves the intelligent traffic systems, education and industrial campus, airport, smart city, rail, military, energy, oil and gas, and water sectors. The company was founded in 1998 and is based in Fremont, California.
URL
https://www.x4pharma.com/
IPO date
Nov 16, 2017
Employees
40
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,557
 
Cost of revenue
82,440
74,013
63,052
Unusual Expense (Income)
NOPBT
(79,883)
(74,013)
(63,052)
NOPBT Margin
Operating Taxes
310
78
28
Tax Rate
NOPAT
(80,193)
(74,091)
(63,080)
Net income
(37,450)
-62.98%
(101,167)
7.78%
(93,867)
5.83%
Dividends
Dividend yield
Proceeds from repurchase of equity
59,999
122,631
BB yield
-40.24%
-194.40%
Debt
Debt current
1,251
2,198
2,513
Long-term debt
4,071
60,893
40,708
Deferred revenue
Other long-term liabilities
88,601
16,115
23,304
Net debt
(96,738)
(51,125)
(79,522)
Cash flow
Cash from operating activities
(130,901)
(96,512)
(77,102)
CAPEX
(326)
(60)
(103)
Cash from investing activities
66,990
(14,883)
(103)
Cash from financing activities
20,294
88,516
117,230
FCF
(78,639)
(72,153)
(61,189)
Balance
Cash
102,060
114,216
121,718
Long term investments
1,025
Excess cash
101,932
114,216
122,743
Stockholders' equity
(515,306)
(477,857)
(376,735)
Invested Capital
630,127
604,451
512,510
ROIC
ROCE
EV
Common stock shares outstanding
201,062
177,812
63,526
Price
0.73
-12.51%
0.84
-15.56%
0.99
-56.64%
Market cap
147,499
-1.07%
149,096
136.35%
63,081
6.98%
EV
50,761
97,971
(16,441)
EBITDA
(79,087)
(73,594)
(62,539)
EV/EBITDA
0.26
Interest
8,768
5,777
3,993
Interest/NOPBT